Tumor cells with stem cell properties are considered to play major roles in promoting the
development and malignant behavior of aggressive cancers. Therapeutic strategies that …

Label-free identification of tumor cells using spectroscopic assays has emerged as a
technological innovation with a proven ability for rapid implementation in clinical care …

Simple Summary The malignant growth and therapy resistance of isocitrate dehydrogenase
(IDH)-wildtype glioblastoma is thought to be driven by a subpopulation of tumor cells with …

Dendritic molecules bearing metal complexes in their structure (metallodendrimers and
metallodendrons) are considered prospective therapeutic entities. In particular …

Glioblastoma (GBM) is the most commonly occurring and most aggressive primary brain
tumor. Transcriptomics-based tumor subtype classification has established the …

Identifying new substances that could potentially be used for tumor therapy and the precise
analysis of their spectrum of action requires models that are as similar as possible to the …

Limitations in genetic stability and recapitulating accurate physiological disease properties
challenge the utility of patient‐derived (PD) cancer models for reproducible and translational …

Background: The conserved stem cell signaling network canonical Wingless (WNT) plays
important roles in development and disease. Aberrant activation of this pathway has been …

Glioblastoma (GBM) is the most common primary brain tumor with has a median survival of
only 14 months. Currently, surgery and postoperative adjuvant chemoradiotherapy remain …

Dendritic molecules bearing metal complexes in their structure (metallodendrimers and
metallodendrons) are considered prospective therapeutic entities. In particular …